INTELISYS HEALTH Trademark
Trademark Overview
On Sunday, November 17, 2024, a trademark application was filed for INTELISYS HEALTH with the United States Patent and Trademark Office. The USPTO has given the INTELISYS HEALTH trademark a serial number of 98857613. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Sunday, November 17, 2024. This trademark is owned by InteliSys Health, LLC. The INTELISYS HEALTH trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Platform and process for point-of-care real-time cash price comparison of prescription medications providing the lowest cost pharmacies and mail order facilities, which is integrated directly into Electronic Medical Records (EMR) systems and within the e-Prescribing workflow to be accessible to health care providers and the patient during and within the Patient/health care provider encounter and in advance of the transmission of the prescription to the selected and designated pharmacies; Platform and process which provides alternative drug options to payor's and insurers including health care plans, self-insured employers, pharmacy benefit managers, health insurance carriers, and other stakeholders, which is integrated directly into Electronic Medical Records (EMR) systems and seeks and recommends in real-time alternative and clinically/therapeutically equivalent and applicable drug therapies at the lowest cost; Platform and process for the delivery of real-time prescription fill, re-f...
General Information
Serial Number | 98857613 |
Word Mark | INTELISYS HEALTH |
Filing Date | Sunday, November 17, 2024 |
Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
Status Date | Sunday, November 17, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Platform and process for point-of-care real-time cash price comparison of prescription medications providing the lowest cost pharmacies and mail order facilities, which is integrated directly into Electronic Medical Records (EMR) systems and within the e-Prescribing workflow to be accessible to health care providers and the patient during and within the Patient/health care provider encounter and in advance of the transmission of the prescription to the selected and designated pharmacies; Platform and process which provides alternative drug options to payor's and insurers including health care plans, self-insured employers, pharmacy benefit managers, health insurance carriers, and other stakeholders, which is integrated directly into Electronic Medical Records (EMR) systems and seeks and recommends in real-time alternative and clinically/therapeutically equivalent and applicable drug therapies at the lowest cost; Platform and process for the delivery of real-time prescription fill, re-fill, and abandoned prescription claim data to the Electronic Medical Record (EMR) system, health care provider, plan, self-insured employer, pharmacy benefit manager or health insurance carrier, and alerts the health care provider or prescriber of any abnormalities in drug therapy adherence and compliance |
Classification Information
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Sunday, November 17, 2024 |
Primary Code | 042 |
First Use Anywhere Date | Saturday, June 10, 2017 |
First Use In Commerce Date | Saturday, June 10, 2017 |
Trademark Owner History
Party Name | InteliSys Health, LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Sheridan, WY 82801 |
Trademark Events
Event Date | Event Description |
Sunday, November 17, 2024 | NEW APPLICATION ENTERED |